The link between insulin clearance and atherosclerosis is further underlined by findings from rodents: knockout of CEACAM1, the central protein for insulin clearance in the liver, causes hyperinsulinemia and marked endothelial dysfunction and formation of atherosclerotic plaques29,30. This evidence concerns the gene CEACAM1 and atherosclerosis.